Aerpio Pharmaceuticals, Inc.
HPTP-BETA INHIBITORS

Last updated:

Abstract:

Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for conditions associated with angiogenesis, for example, ocular conditions. Formulations for increased solubility are disclosed.

Status:
Application
Type:

Utility

Filling date:

2 Oct 2020

Issue date:

6 May 2021